A Research To Evaluate The Relationship Regarding Steatotic Liver Damage Or Metabolic Dysfunction: A Comprehensive Analysis Of A Complex Issue
DOI:
https://doi.org/10.52783/jns.v14.3167Keywords:
Steatotic liver disease, dysfunction of metabolism, diagnosisAbstract
Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common; it affects over 25% of the global population and over 60% of those at high risk. It raises the probability of metabolic syndrome, which includes several diseases affecting the liver and cardiovascular system. The intricacy of NAFLD, as well as the comorbidities and complications that often accompany it, make a multidisciplinary approach to treatment essential. Experts are concerned about the lack of understanding regards to NAFLD, including its seriousness, potential consequences, comorbidities, and what to do if NAFLD is found. Those who have cirrhosis, inflexible simple steatosis, hepatocellular cancer, or cardiovascular disease and are actively metabolizing non-alcoholic steatosis (NASH) need to be located. This could be difficult since there are competing opinions on the best ways to diagnose and treat the problem. Before discussing possible future prospects for multidisciplinary care route development, the researchers review the history of NAFLD, its diagnostics, and treatment choices.
Downloads
Metrics
References
Tamaki N, Munaganuru N, Jung J, Yonan AQ, Loomba RR, Bettencourt R, Ajmera V, Valasek MA, Behling C, Sirlin CB, Loomba R. Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. Gut. 2022; 71:983–990.
Lubner MG, Graffy PM, Said A, Watson R, Zea R, Malecki KM, Pickhardt PJ. Utility of Multiparametric CT for Identification of High-Risk NAFLD. AJR Am J Roentgenol. 2021; 216:659–668.
Boursier J, Hagström H, Ekstedt M, Moreau C, Bonacci M, Cure S, Ampuero J, Nasr P, Tallab L, Canivet CM, Kechagias S, Sánchez Y, Dincuff E, Lucena A, Roux M, Riou J, Trylesinski A, Romero-Gomez M. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events. J Hepatol. 2022; 76:1013–1020.
Hamurcu Varol P, Kaya E, Alphan E, Yilmaz Y. Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients. Eur J Gastroenterol Hepatol. 2020; 32:1352–1357.
Ng CH, Lin SY, Chin YH, Lee MH, Syn N, Goh XL, Koh JH, Quek J, Hao Tan DJ, Mok SF, Tan E, Dan YY, Chew N, Khoo CM, Siddiqui MS, Muthiah M. Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence from a Network Meta-Analysis of Randomized Controlled Trials. Endocr Pract. 2022; 28:223–230.
Chauhan M, Singh K, Thuluvath PJ. Bariatric Surgery in NAFLD. Dig Dis Sci. 2022; 67:408–422.
Chew NWS, Ng CH, Truong E, Noureddin M, Kowdley KV. Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update. Semin Liver Dis. 2022; 42:379–400.
Horn P, Newsome PN. Nonalcoholic Fatty Liver Disease. N Engl J Med. 2022; 386:294.
Battistella S, D'Arcangelo F, Grasso M, Zanetto A, Gambato M, Germani G, Senzolo M, Russo FP, Burra P. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management. Clin Mol Hepatol. 2023;29: S286–S301.
Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022; 7:851–861.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
